Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct;37(14):3049.
doi: 10.1038/s41433-023-02456-5. Epub 2023 Feb 24.

Comment on: 'The expanding spectrum of idiopathic intracranial hypertension'

Edward J Bilton  1 , Alexandra J Sinclair  2   3 , Susan P Mollan  4   5
Affiliations
Comment

Comment on: 'The expanding spectrum of idiopathic intracranial hypertension'

Edward J Bilton et al. Eye (Lond). 2023 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

EJB has no conflicts of interests to declare. AJS reports honoria for speaker events from Teva. Consulting fees from Invex therapeutics; salary and stockholding with Invex therapeutics. SPM reports consultancy fees (Invex Therapeutics); advisory board fees (Invex therapeutics; Gensight) and speaker fees (Heidelberg engineering; Chugai-Roche Ltd; Allergan; Santen; Chiesi; and Santhera).

Comment on

References

    1. Biousse V, Newman NJ. The expanding spectrum of idiopathic intracranial hypertension. Eye (Lond). 2022. 10.1038/s41433-022-02361-3. - PMC - PubMed
    1. Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ. Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension: a population-based matched cohort study. Neurology. 2022. 10.1212/WNL.0000000000201064 - PMC - PubMed
    1. Thaller M, Homer V, Hyder Y, Yiangou A, Liczkowski A, Fong AW, et al. The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol. 2022. 10.1007/s00415-022-11402-6. - PMC - PubMed
    1. Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89:1088–100. doi: 10.1136/jnnp-2017-317440. - DOI - PMC - PubMed
    1. Mitchell J, Mollan S, Walker J, Buckham R, Lyons H, Yiangou A, et al. A randomised controlled, trial of the GLP-1 receptor agonist exenatide in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2022;93:A98. doi: 10.1136/jnnp-2022-ABN.317. - DOI

LinkOut - more resources